Inventor · disambiguated record
Wensheng Yu
Also filed as: YU WENSHENG
50 granted patents·17 pending applications·350 citations·filing 2001–2025
98Inventor score
Files withMERCK SHARP & DOHME20SCHERING CORP15SHANGHAI HANSOH BIOMEDICAL CO LTD11MERCK SHARP & DOHME LLC8KOZLOWSKI JOSEPH A2
Top patents by PatentIndex Score
67 records- 0196US7566718B2Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Jul 28, 2009·73 cites·41 claims
- 0295US7488745B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Feb 10, 2009·23 cites·34 claims
- 0392US8178553B2Compounds for the treatment of inflammatory disordersLAVEY BRIAN J·Filed 2010·Granted May 15, 2012·46 cites·19 claims
- 0492US7524842B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Apr 28, 2009·19 cites·34 claims
- 0592US7504424B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2006·Granted Mar 17, 2009·24 cites·3 claims
- 0691US8569336B2Compounds for the treatment of inflammatory disordersTONG LING·Filed 2009·Granted Oct 29, 2013·44 cites·4 claims
- 0791US7482370B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 27, 2009·20 cites·79 claims
- 0888US7879890B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Feb 1, 2011·6 cites·11 claims
- 0986US7772263B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2009·Granted Aug 10, 2010·7 cites·31 claims
- 1086US7763616B2Piperazine-piperidines with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Jul 27, 2010·10 cites·7 claims
- 1186US7687527B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 30, 2010·8 cites·9 claims
- 1285US7868005B2Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Jan 11, 2011·9 cites·29 claims
- 1384US7879838B2Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Feb 1, 2011·10 cites·28 claims
- 1484US7683085B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 23, 2010·6 cites·10 claims
- 1583US9555038B2Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·6 cites·24 claims
- 1682US12091405B2Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 17, 2024·2 cites·13 claims
- 1782US7652020B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 26, 2010·5 cites·48 claims
- 1881US12152019B2Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 26, 2024·2 cites·20 claims
- 1979US9598440B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2013·Granted Mar 21, 2017·6 cites·5 claims
- 2078US8609635B2Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseasesNAIR ANILKUMAR GOPINADHAN·Filed 2011·Granted Dec 17, 2013·8 cites·39 claims
- 2175US8361959B2Spiro-imidazolone derivatives as glucagon receptor antagonistsMERCK SHARP & DOHME·Filed 2009·Granted Jan 29, 2013·2 cites·18 claims
- 2274US7683088B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Mar 23, 2010·1 cites·19 claims
- 2373US9828365B2Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Nov 28, 2017·2 cites·21 claims
- 2472US9481682B2Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 1, 2016·2 cites·23 claims
- 2572US8541572B2Compounds for the treatment of inflammatory disordersKOZLOWSKI JOSEPH A·Filed 2009·Granted Sep 24, 2013·2 cites·4 claims
- 2666US10087188B2Benzamide imidazopyrazine Btk inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 2, 2018·1 cites·2 claims
- 2762US2011286969A1Deuterated compounds as hepatitis c virus (hcv) inhibitorsMACCOSS MALCOLM·Filed 2009·Application pending·0 cites
- 2861US6953780B2Endothelin antagonistINST PHARM & TOXICOLOGY AMMS·Filed 2001·Granted Oct 11, 2005·3 cites·9 claims
- 2960US12497366B2Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Granted Dec 16, 2025·0 cites·15 claims
- 3058US2025152564A1Propylene ketone-containing bioinhibitor, preparation method therefor, and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 3157US6753414B2Process for preparing saponin compoundsUNIV IOWA RES FOUNDATION INC·Filed 2002·Granted Jun 22, 2004·3 cites·22 claims
- 3257US2025059196A1Tricyclic derivative inhibitor, preparation method therefor, and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 3356US2025368616A1Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 3456US2025206718A1Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 3555US2024360109A1Cycloalkene derivative regulator, preparation method therefor, and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 3655US2025066360A1Pyridine-containing polycyclic derivative, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 3754US2024208981A1Nitrogen-containing heterocyclic polycyclic compound, preparation method therefor, and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 3854US2025388578A1Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Application pending·0 cites
- 3953US12281109B2Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetesMERCK SHARP & DOHME LLC·Filed 2020·Granted Apr 22, 2025·0 cites·13 claims
- 4053US12157727B2Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Dec 3, 2024·0 cites·20 claims
- 4153US2024228490A1Heterocyclic derivative inhibitor and preparation method therefor and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 4252US11976069B2Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infectionMERCK SHARP & DOHME LLC·Filed 2020·Granted May 7, 2024·0 cites·12 claims
- 4352US2025051316A12-(aryl-2-yl) morpholine and deuterated derivative thereof, preparation method therefor and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 4451US12331044B2Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infectionMERCK SHARP & DOHME LLC·Filed 2019·Granted Jun 17, 2025·0 cites·12 claims
- 4550US12275729B2Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2018·Granted Apr 15, 2025·0 cites·5 claims
- 4649US11103493B2Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Aug 31, 2021·0 cites·18 claims
- 4749US2016257697A1Thiophene-substituted tetracyclic compounds and methods ofuse thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 4848US12264134B2Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·0 cites·21 claims
- 4948US11111232B2Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Sep 7, 2021·0 cites·20 claims
- 5047US11498904B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Nov 15, 2022·0 cites·14 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wensheng Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →